Organisation paid for research Program year 2025 Source: CMS Open Payments

Invicro LLC

Neither a doctor nor a teaching hospital

Research payments

$2,216,376

76 payments

Through program year 2025, Invicro LLC is reported as receiving $2,216,376 in research payments, across 76 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$150,571	10
2024	Research	$465,162	26
2023	Research	$501,065	22
2020	Research	$409,550	9
2019	Research	$690,028	9

Breakdown

Who paid Research payments · program years 2019–2025

Neurocrine Biosciences, Inc. $1,099,577 18 payments
AbbVie, Inc. $884,093 43 payments
Roche TCRC, Inc. $139,767 8 payments
H. Lundbeck A S $85,134 6 payments
Eisai Inc. $7,804 1 payment

Studies the money was for Research payments · program years 2019–2025

M23-471 Ph1b Target Occupancy PET $877,196 40 payments
An Open-Label, Positron Emission Tomography Study in Healthy Adult Male Subjects to Investigate Vesicular Monoamine Transporter 2 Target Occupancy of Single Oral Doses of Nbi-750142, Using 18Fav-133 $690,028 9 payments
An Open-Label, Positron Emission Tomography Study in Healthy Adult Male Subjects to Investigate Vesicular Monoamine Transporter 2 Target Occupancy of Single Oral Doses of Nbi-750142, Using [18F]Av-133 $409,550 9 payments
Phase II Study in Early Stage Parkinson S Disease Patients $139,767 8 payments
Binding and Effects of Lu AG06466 in the Brain of Healthy Men $85,134 6 payments
A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease $7,804 1 payment
M23-471 Ph1b Target Occupancy PET $3,679 1 payment
M23-471 - M23-471 Ph1b Target Occupancy PET $3,000 1 payment
M23-471 Ph1b Target Occupancy PET $218 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.